Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Budina

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Nature Biomedical Engineering|May 9, 2022
Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linkerAslan Mansurov, Peyman Hosseinchi, Kevin Chang, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
Precision mRNA Nanomedicine for Targeted Vascular Therapies in ARDS and AtherosclerosisZhengjie Zhou, Jiayu Zhu, Chih-Fan Yeh, et al.
JCI Insight|August 8, 2025
A prometabolite strategy inhibits cardiometabolic disease in an ApoE-/- murine model of atherosclerosisTaryn N Beckman, Lisa R Volpatti, Salvador Norton de Matos, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Serum albumin-fused interleukin-10 prevents neuroinflammation by promoting immunoregulation in the secondary lymphoid organs and limiting immune cell infiltration in the spinal cordErica Budina, Joseph W Reda, Kirsten C Refvik, et al.
Nature Biomedical Engineering|April 1, 2024
A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in miceShijie Cao, Erica Budina, Michal M Raczy, et al.
Cell Reports. Medicine|July 8, 2025
Activity-attenuated serum albumin-fused interleukin-33 suppresses experimental autoimmune encephalomyelitisErica Budina, Joseph W Reda, Shijie Cao, et al.
Nature Biomedical Engineering|September 7, 2023
Synthetically glycosylated antigens for the antigen-specific suppression of established immune responsesAndrew C Tremain, Rachel P Wallace, Kristen M Lorentz, et al.
Biomaterials|October 11, 2021
Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvantLaura T Gray, Michal M Raczy, Priscilla S Briquez, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 8, 2017
Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviorsYu Shrike Zhang, Julio Aleman, Su Ryon Shin, et al.
Biomaterials|May 19, 2026
Corrigendum to 'Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant' [Biomaterials, 128 (2021), 121159]Laura T Gray, Michal M Raczy, Priscilla S Briquez, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Nature Biomedical Engineering|May 9, 2022
Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linkerAslan Mansurov, Peyman Hosseinchi, Kevin Chang, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
Precision mRNA Nanomedicine for Targeted Vascular Therapies in ARDS and AtherosclerosisZhengjie Zhou, Jiayu Zhu, Chih-Fan Yeh, et al.
JCI Insight|August 8, 2025
A prometabolite strategy inhibits cardiometabolic disease in an ApoE-/- murine model of atherosclerosisTaryn N Beckman, Lisa R Volpatti, Salvador Norton de Matos, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Serum albumin-fused interleukin-10 prevents neuroinflammation by promoting immunoregulation in the secondary lymphoid organs and limiting immune cell infiltration in the spinal cordErica Budina, Joseph W Reda, Kirsten C Refvik, et al.
Nature Biomedical Engineering|April 1, 2024
A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in miceShijie Cao, Erica Budina, Michal M Raczy, et al.
Cell Reports. Medicine|July 8, 2025
Activity-attenuated serum albumin-fused interleukin-33 suppresses experimental autoimmune encephalomyelitisErica Budina, Joseph W Reda, Shijie Cao, et al.
Nature Biomedical Engineering|September 7, 2023
Synthetically glycosylated antigens for the antigen-specific suppression of established immune responsesAndrew C Tremain, Rachel P Wallace, Kristen M Lorentz, et al.
Biomaterials|October 11, 2021
Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvantLaura T Gray, Michal M Raczy, Priscilla S Briquez, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 8, 2017
Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviorsYu Shrike Zhang, Julio Aleman, Su Ryon Shin, et al.
Biomaterials|May 19, 2026
Corrigendum to 'Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant' [Biomaterials, 128 (2021), 121159]Laura T Gray, Michal M Raczy, Priscilla S Briquez, et al.
Pageof 3